Dataset v2026-08-31 59 providers tracked 72% of prices verified within 7 days Every price carries a source, a date and a grade. How we verify

Ro GLP-1 pricing

As of August 31, 2026:

Ro does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name pen at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.

Provider ID
prv_ro
Canonical name
Ro
Also known as
—
Official domain
ro.co
Provider type
insurance first
Pricing model
insurance first
Membership fee
not published
Dose pricing
increasing
Shipping
included
Consultation
included
Price lock stated
not stated
Commitment
month-to-month membership
Cancellation
Cancel anytime
Pharmacies (provider-stated)
LillyDirect (Zepbound vials), NovoCare Pharmacy (Wegovy)
Pharmacy classification (provider-stated)
brand
States served
all-50
Affiliate relationship with this site
none recorded
Record last verified
August 25, 2026

Every published plan

Ro: every plan with a published or reported price. Unpriced protocols are omitted rather than guessed.
MedicationFormulationPlanAdvertised /moMaintenance-dose /moAll-in /mo12-month all-inGradeVerifiedSource
tirzepatidebrand-name penmonth-to-month$299$449$449$4,977Bro.co

Notes from verification

  • tirzepatide, month-to-month: Brand-name Zepbound at Lilly's conditional Self Pay Journey prices: $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg, plus Ro's Body membership ($39 the first month, then commitment-dependent; about $74 per month on an annual plan and higher month-to-month, amount not fixed publicly).

Listed without a price

  • semaglutide, brand pen: Brand Wegovy: promotional low-dose pricing may apply to initial fills; ongoing self-pay pricing is dose and offer dependent and is billed separately from the membership.

Price history

No changes recorded yet for Ro; history starts with dataset v2026-08-31. Every future change lands here and in the site-wide log.

Full price-history page

Regulatory records

None on file for Ro. Per the regulatory policy, only events matched to a primary source are published.

First-party price sources

Data

This record as JSON: /providers/ro/data.json · API: /api/v1/providers/ro.json · Cite as “GLP-1 Price Compare, Ro Pricing, verified August 25, 2026”. Wrong? File a correction.

Questions this page answers

How much does Ro cost?

Ro does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name pen at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.